The Feed Additives (Authorisations) and Uses of Feed Intended for Particular Nutritional Purposes (Amendment of Commission Regulation (EU) 2020/354) (England) Regulations 2024

Modification of authorisation: a preparation of Bacillus velezensis (DSM 15544), (identification number 4b1820)

5.—(1) Commission Implementing Regulation (EU) 2016/897 concerning the authorisation of a preparation of Bacillus subtilis (C-3102) (DSM 15544) as a feed additive for laying hens and ornamental fish, etc.(1), is amended as follows—

(a) omit Articles 2 to 4;

(b) in the Annex, in the table:

(i) in the second column (name of the holder of authorisation), for “Asahi Calpis Wellness” to the end substitute “Asahi Biocycle Co., Ltd”;

(ii) in the third column (additive) and the fourth column (composition, etc.), for “Bacillus subtilis C-3102”, in each place, substitute “Bacillus velezensis”;

(iii) in the fifth column (species or category of animal), omit “Laying hens”;

(iv) in the seventh column (minimum content), omit “3 x 10⁸”.

(2) In Commission Implementing Regulation (EU) 2017/2312 concerning the authorisation of a new use of the preparation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for sows, suckling piglets and dogs, etc.(2), in the Annex, the table is amended as follows—

(a) in the second column (name of the holder of authorisation), for “Asahi Calpis Wellness” to the end substitute “Asahi Biocycle Co., Ltd”;

(b) in the third column (additive) for “Bacillus subtilis” substitute “Bacillus velezensis”;

(c) in the fourth column (composition, etc.)—

(i) in the section headed “Additive composition”, for “Bacillus subtilis C-3102” substitute “Bacillus velezensis”;

(ii) in the section headed “Characterisation of the active substance”, for “Bacillus subtilis” substitute “Bacillus velezensis”.

(3) In Commission Implementing Regulation (EU) 2018/1081 concerning the authorisation of the preparation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive for pigs for fattening, etc.(3), in the Annex, the table is amended as follows—

(a) in the second column (name of the holder of authorisation), for “Asahi Calpis Wellness” to the end substitute “Asahi Biocycle Co., Ltd”;

(b) in the third column (additive) and the fourth column (composition, etc.), for “Bacillus subtilis C-1302”, in each place, substitute “Bacillus velezensis”.

(1)

EUR 2016/897.

(2)

EUR 2017/2312.

(3)

EUR 2018/1081.